Papillomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: Bevacizumab;   Drug: Cidofovir;   Other: PlaceboSponsor:   Centro de Investigación en. Enfermedades Infecciosas, MexicoRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials